Fatty Liver Blood Tests: 7 Markers & Imaging Explained

You might know the feeling: a slight pressure under your right rib cage, afternoon fatigue, and the thought that your diet and exercise habits could have been better in recent years. Fatty liver disease is one of the most common chronic liver conditions, causing silent damage: over years, fat accumulates in the liver cells, often without causing noticeable symptoms.

Many people rely on the standard liver values from their primary care physician. But normal results do not rule out a fatty liver. A single fatty liver blood test is not enough to reliably assess your liver health.

A reliable assessment requires three components: meaningful blood tests, liver imaging, and an evaluation of your metabolic risk profile.

Overview of Fatty Liver Blood Tests

\Normal ranges can vary by laboratory, sex, and age, and are provided here for orientation only.*

What is a Fatty Liver? MASLD, MetALD, and the Silent Risk

The liver performs hundreds of functions in the body. It filters metabolic byproducts, stores glycogen, produces bile, and regulates blood sugar. When too much fat accumulates in its cells, the organ comes under pressure. Medically, this is referred to as hepatic steatosis.

Since 2023, these conditions have been grouped under the umbrella term Steatotic Liver Disease (SLD) and differentiated by their cause:

• Metabolic dysfunction-associated steatotic liver disease (MASLD): The most common form. It occurs when liver fat accumulation is present alongside at least one cardiometabolic risk factor, such as overweight, insulin resistance/type 2 diabetes, high blood pressure, or a lipid metabolism disorder. It was previously known as "non-alcoholic fatty liver disease" (NAFLD).
• MetALD: A mixed form where both metabolic risk factors and increased alcohol consumption play a role.
• Alcohol-associated liver disease (ALD): Here, alcohol is the primary cause of fat accumulation.

Estimates suggest that about 30% of adults worldwide are affected by a fatty liver condition (MASLD or formerly NAFLD). Similar figures are assumed for Western nations. Many are unaware of it. In the early stages, the process can be reversible. Adjustments in diet, exercise, and body weight can help achieve this.

Why Early Detection is Crucial

A fatty liver disease develops insidiously and, if left untreated, can progress over years:

1. Simple Steatosis (MASL): Pure fat accumulation without significant inflammation.
2. Steatohepatitis (MASH): In addition to fat accumulation, inflammation and cell damage occur in the liver.
3. Liver Fibrosis: Chronic inflammation can lead to progressive scarring of the liver tissue.
4. Liver Cirrhosis: In the end stage, the liver hardens, its structure is severely altered, and its function is significantly impaired. The risk of liver cancer (hepatocellular carcinoma, HCC) increases significantly.

The decisive factor for the prognosis is the degree of fibrosis. Detecting or ruling this out early is a central goal of modern preventive diagnostics. Furthermore, MASLD is associated with an increased risk of cardiovascular disease and type 2 diabetes. When you think about your liver, you are simultaneously thinking about your overall metabolic health.

Which Fatty Liver Blood Tests Reveal the Disease?

No single blood test can confirm a fatty liver. A comprehensive analysis includes liver enzymes (ALT, AST, GGT) and crucial metabolic markers like the HOMA index (insulin resistance) and triglycerides. Inflammatory markers like hs-CRP provide important context. Only the combination of these values, supplemented by risk scores and imaging, provides a reliable picture of your liver health.

Classic Liver Enzymes: ALT, AST, and GGT

Classic liver enzymes provide an initial clue but are often insufficient for a reliable diagnosis.

• ALT (Alanine Aminotransferase): Can indicate damage to liver cells but remains within the normal range for many affected individuals despite a fatty liver.
• AST (Aspartate Aminotransferase): Also found in heart and skeletal muscle. The ratio of AST to ALT can provide additional diagnostic clues.
• GGT (Gamma-Glutamyl Transferase): Reacts nonspecifically to many influences (alcohol, medications, metabolism) and is therefore of limited value on its own.

Important Metabolic Markers in the Context of Fatty Liver

In addition to isolated liver enzymes, markers that describe your entire metabolic situation are important:

• HOMA Index: Calculated from fasting insulin and fasting blood sugar, this value is an established indicator of insulin resistance, one of the main drivers of fatty liver.
• Triglycerides: Elevated blood lipids are a classic risk factor and frequently occur together with MASLD.
• Ferritin: This iron storage marker can also be elevated during inflammation and metabolic disorders, but it is nonspecific.
• hs-CRP: A marker for systemic, low-grade inflammation, which often accompanies metabolic diseases.

The Limits of Fatty Liver Blood Tests Alone: Why Imaging is Important

Blood tests are a window into the function of your liver, but they cannot directly show its structure. You can have a fatty liver even if your ALT, AST, and GGT levels are within the reference range.

Pure fat accumulation does not necessarily lead to the release of liver enzymes. In practice, this means: an ALT value of 28 U/l is considered unremarkable in most laboratories. At the same time, the fat content of the liver can already be 20% or more. Even with inflammation (MASH) or early fibrosis, these values can lie within the normal range.

A blood test alone is therefore not a reliable criterion for ruling out the disease. It shows stress, but not necessarily the underlying structural change.

Modern Diagnostics: Ultrasound, FibroScan, and MRI Compared

Since blood tests alone are not enough, imaging comes into play. It assesses the liver structure directly.

An ultrasound reliably detects fat accumulation only from a fat content of about 20 to 30%. Below that, the examination provides hints at best. Nevertheless, an abdominal ultrasound is a sensible starting point. It is part of the YEARS Core® Program and can provide indications within minutes as to whether the liver is fatty or if other structural abnormalities are present.

Note: FibroScan® (elastography) is listed in this overview as a general method and is not part of the YEARS programs.

Understanding Risk Scores: What FIB-4 and Fatty Liver Index (FLI) Mean

To better assess individual risk, doctors use non-invasive scores that combine various laboratory values and parameters.

• Fatty Liver Index (FLI): Calculated from BMI, waist circumference, GGT, and triglycerides. A score below 30 makes a fatty liver unlikely, a score of 60 or above makes it likely. It serves as a simple screening tool.
• FIB-4 Score: This is a clinically central score for assessing fibrosis risk. It is calculated from age, AST, ALT, and platelet count. A value below 1.3 is considered (for those under 65) a low risk for advanced fibrosis; for individuals aged 65 and older, a higher threshold (approx. 2.0) is used.

Modern guidelines recommend a step-by-step approach: First, the FIB-4 score is determined in at-risk individuals. If this falls into an unclear or elevated range, the next step follows, such as liver elastography.

Who Should Get Tested for a Fatty Liver?

A targeted evaluation is sensible if you have one or more of the following risk factors:

• Overweight or obesity, especially abdominal fat
• Type 2 diabetes or prediabetes
• Known insulin resistance
• Metabolic syndrome (a combination of abdominal fat, high blood pressure, and impaired glucose and lipid metabolism)
• Elevated triglycerides or low HDL cholesterol
• High blood pressure

Even lean individuals can develop a fatty liver ("Lean MASLD") if a metabolic disorder is present. Your overall risk profile is decisive, not just your BMI.

Fatty Liver Early Detection at YEARS

At YEARS, we view your liver health in the context of your entire metabolism. Our goal is to identify risks early so that you can act in time.

The YEARS Core® Program (€1,900) provides you with a solid data foundation for this:

• Comprehensive laboratory panel (87+ biomarkers): This includes liver values as well as metabolic markers like the HOMA index, ferritin, hs-CRP, and parameters of lipid and glucose metabolism.
• Ultrasound imaging: As part of the extended abdominal ultrasound, the YEARS medical team can also assess the liver for signs of steatosis and other abnormalities.

For an even more comprehensive analysis, the YEARS Evolve® Program (€7,600) additionally offers a Whole-Body MRI at YEARS. This can make structural abnormalities of the liver and other organs visible.

All results are summarized in your personal Health Report and contextualized in a strategy session with the YEARS medical team. You go home with a foundation for concrete next steps.

Would you like to precisely determine your liver and metabolic status? Schedule a consultation to find the diagnostic approach that is right for you.

A Blood Test Alone Provides No Certainty

A fatty liver can neither be reliably diagnosed nor ruled out with a single blood test. The assessment only becomes robust through the combination of your metabolic risk profile, meaningful laboratory values (like the HOMA index), and an imaging examination such as an ultrasound.

If you have risk factors, it is worth looking at your liver and metabolism early on. How often check-ups make sense depends on your individual risk profile and should be coordinated with a doctor. Regularly collected values create a meaningful trend curve before the first symptoms appear.

---

Frequently Asked Questions (FAQ)

Can I have a fatty liver even if my liver enzymes are normal? Yes. A relevant portion of people with MASLD have normal liver enzymes (ALT, AST). Even more advanced changes can be present despite unremarkable blood tests. Normal values are therefore not a free pass.

Which blood test is best for detecting a fatty liver? There is no single "best" blood test. In addition to liver enzymes, metabolic markers like the HOMA index (insulin resistance) and triglycerides are very revealing. To assess the risk of scarring, the FIB-4 score is a central tool. It is calculated from laboratory values (AST, ALT, platelets) and age.

When is an ultrasound useful if a fatty liver is suspected? An ultrasound is generally useful in cases of abnormal liver values, metabolic risk factors (e.g., overweight, diabetes), or a justified medical suspicion. It is one of the most widely used initial examinations to detect steatosis.

Can a fatty liver be reversed? In particular, a simple fatty liver without relevant inflammation can often be reversed. A weight reduction of about 5% can measurably lower the liver fat content. From a 7–10% weight loss, inflammatory activity (MASH) frequently improves as well. A regression of fibrosis is more likely observed from approx. 10% weight loss. The individual course varies and should be medically supervised.

This article is for general informational purposes only and does not replace individual medical advice, diagnosis, or treatment. The content is based on the scientific consensus at the time of publication.

Sources

• Bedogni, G., Bellentani, S., Miglioli, L., et al. (2006). The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology, 6, 33.
• EASL–EASD–EASO. (2024). Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Journal of Hepatology, 81(3), 492–542.
• Fracanzani, A. L., Valenti, L., Bugianesi, E., et al. (2008). Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology, 48(3), 792–798.
• Rinella, M. E., Lazarus, J. V., Ratziu, V., et al. (2023). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Journal of Hepatology, 79(6), 1542–1556.
• Riazi, K., Azhari, H., Charette, J. H., et al. (2022). The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 7(9), 851–861.

---

Summary of Review

• YEARS Program Details: Prices, biomarkers (HOMA, ferritin, hs-CRP, liver values), ultrasound (Core), and whole-body MRI (from Evolve®) match the reference. There are no mix-ups with hepatitis, spirometry, or hormones.
• Corrected:

- Absolute claims regarding MRI ("highest precision") removed. - Ultrasound statement formulated without contradiction and conditionally. - MASL/MASLD terminology corrected. - FIB-4 threshold supplemented with age reference. - Sex-specific reference values added. - Blanket "from 35" recommendation removed. - "500 functions" removed and "frequently normal in MASH" softened. - FibroScan® clarified as not included in the YEARS offering.

• Citations and Statistics: The source details (volumes and pages) are plausible. The prevalence of approx. 30% and the weight loss thresholds (5% / 7–10% / ≥10%) correspond to the literature.
• Open Point: Frontmatter and title are in English, the article text in German. Please review editorially.